Found 297 matching trials
Anlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer PHASE2 Small Cell Lung cancer (SCLC) is a highly aggressive tumor that accounts fo...
Show More Location
Sixth People's Hospital of Luoyang
Learn More & Join Trial
Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC PHASE2 This phase II trial compares the effect of adding radiation therapy to the ...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
Evaluation of the Effectiveness of the Parkinson Specialized Teams Intervention NA A pilot experiment interventional study is proposed in order to set up mult...
Show More Location
Hopital Pellegrin
Learn More & Join Trial
A Study of Concurrent Chemoradiation With Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) PHASE2 Etoposide-cisplatin/ -carboplatin in combination with PD-L1 inhibitor for 4...
Show More Location
Hunan cancer hospital
Learn More & Join Trial
A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer PHASE3 Study GO43104 is a Phase III, randomized, open-label, multicenter study of ...
Show More Status
Active Not Recruiting
Location
Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital
Learn More & Join Trial
Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss PHASE2 Explore weight gain in HIV-positive patients who have weight loss associate...
Show More Location
Drexel University College of Medicine
Learn More & Join Trial
A Phase II Study of Ivonescimab Combined with Cadonilimab and Chemotherapy in Extensive-stage Small Cell Lung Cancer PHASE2 The goal of this clinical trial is to investigate the efficacy, safety and ...
Show More Location
Multiple Locations
Learn More & Join Trial
Combination of Atezolizumab With Dendritic Cell Vaccine in Patients With Lung Cancer PHASE1 This is a single-arm Phase Ib/II multicenter open-label study, with transla...
Show More Learn More & Join Trial
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer PHASE1 The purpose of this study is to assess the safety and tolerability of BMS-9...
Show More Location
Karmanos Cancer Institute
Learn More & Join Trial
Anti-PD-1 and VEGF Bispecific Antibody AK112 in Combination With Chemotherapy in Patients With ES-SCLC PHASE1 Phase Ib open label, multicenter study to evaluate the efficacy and safety ...
Show More Learn More & Join Trial